Abstract
The KEL1 antigen can give rise to immunization of KEL2 mothers. Maternal antibodies can be transferred to the fetus and destroy fetal red blood cells and their stem cell precursors and give rise to serious fetal disease. It is important to be able to predict the fetal KEL status in order to intervene in those pregnancies where the fetus is at risk, and to ascertain when the fetus is not at risk. Technically it can be demanding to predict KEL1 status from a maternal blood sample. The KEL1 allele is based on a single SNP present in about 1–10 % of cell-free maternal DNA after gestation week 10. Here we describe our protocol for antenatal prediction of fetal KEL1 status by NGS analysis of maternal DNA on a MiSeq instrument.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nordvall M, Dziegiel M, Hegaard HK, Bidstrup M, Jonsbo F, Christensen B, Hedegaard M (2009) Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion 49:2070–2075
Dziegiel MH, Koldkjær O, Berkowicz A (2005) Massive antenatal fetomaternal hemorrhage evidence for long-term survival of fetal red blood cells. Transfusion 45:539–544
Mathiesen L, Nielsen LK, Andersen JT, Grevys A, Sandlie I, Michaelsen TE, Hedegaard M, Knudsen LE, Dziegiel MH (2013) Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions. Blood 122:1174–1181
Clausen FB, Jakobsen TR, Rieneck K, Krog GR, Nielsen LK, Tabor A, Dziegiel MH (2013) Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD. PLoS One 8:e76990
Rieneck K, Bak M, Jønson L, Clausen FB, Krog GR, Tommerup N, Nielsen LK, Hedegaard M, Dziegel MH (2013) Next generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell free fetal DNA in maternal plasma. Transfusion 53(Suppl 2):2892–2898
Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, Chiu RW (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2:61ra91
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Rieneck, K., Clausen, F.B., Dziegiel, M.H. (2015). Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status. In: Bugert, P. (eds) Molecular Typing of Blood Cell Antigens. Methods in Molecular Biology, vol 1310. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2690-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2690-9_10
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2689-3
Online ISBN: 978-1-4939-2690-9
eBook Packages: Springer Protocols